The present application proposes research projects that will enhance the ability of our institution to conduct drug abuse research. The objectives of this proposal are: 1) to strengthen the institutional infrastructure, 2) To enhance the capability of individual faculty members to perform drug abuse research, and 3) To involve outstanding students in research in order to encourage them to pursue careers in drug abuse research. Two pilot projects and eight individual research subprojects are proposed. The pilot projects will enable the career development of two junior faculty members in drug abuse-related research. The eight drug abuse- related subprojects will enable faculty and outstanding students to accomplish the following specific aims. An evaluation of smoking cessation methods will be performed. The three-dimensional structure and electronic character of cocaine analogs will be determined. An endogenous ligand of the central benzodiazepine receptor will be identified. Slow release drug delivery systems will be developed for treating drug addictions. For example, biodegradable microcapsules containing buprenorphine will be developed and evaluated for release characteristics. In addition, an oral microcapsule formulation of amantidine will be developed and evaluated for release characteristics in in vitro and in vivo experiments. The prevalence of alcoholism in the black adolescent population of Louisiana relative to other ethnic adolescents will be contrasted with socioeconomic and cultural differences in onset of alcohol use, family attitudes and beliefs, peer pressure, school performance, and rational for drinking. New acyclic nucleotide analogs of anti-AIDS will be synthesized as potential anti-HIV agents for treatment of HIV-1 and 3'-azidothymidine (AZT) resistant HIV-1 strains in AIDS patients. Novel anti-Pneumocystis carinii drugs with less hepatotoxicity will be synthesized to enable improved drug therapy of alcoholic AIDS patients with liver damage.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Resource-Related Research Projects (R24)
Project #
2R24DA007970-04
Application #
2120411
Study Section
Special Emphasis Panel (SRCD (02))
Project Start
1992-08-14
Project End
1998-06-30
Budget Start
1995-09-15
Budget End
1996-07-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Xavier University of Louisiana
Department
Other Health Professions
Type
Schools of Pharmacy
DUNS #
020857876
City
New Orleans
State
LA
Country
United States
Zip Code
70125
Mayence, Annie; Vanden Eynde, Jean Jacques; Krogstad, Fran M et al. (2004) Parallel solution-phase synthesis of conformationally restricted congeners of pentamidine and evaluation of their antiplasmodial activities. J Med Chem 47:2700-5
Mayence, Annie; Vanden Eynde, Jean Jacques; LeCour Jr, Louis et al. (2004) Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents. Eur J Med Chem 39:547-53
Homayoun, P; Mandal, T; Landry, D et al. (2003) Controlled release of anti-cocaine catalytic antibody from biodegradable polymer microspheres. J Pharm Pharmacol 55:933-8
Donkor, Isaac O; Huang, Tien L; Tao, Bin et al. (2003) Trypanocidal activity of conformationally restricted pentamidine congeners. J Med Chem 46:1041-8
Mandal, Tarun K; Bostanian, Levon A; Graves, Richard A et al. (2002) Poly(D,L-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system. Pharm Res 19:1713-9
Zhang, Qiang; Ma, Peng; Iszard, Marcus et al. (2002) In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist. Drug Metab Dispos 30:1077-86
Brakta, Mohamed; Murthy, Devangachinta; Ellis, L'Ouverture et al. (2002) 9-[(Hydroxymethyl)phenyl]adenines: new aryladenine substrates of adenosine deaminase. Bioorg Med Chem Lett 12:1489-92
Huang, T L; Tao, B; Quarshie, Y et al. (2001) N,N'-bis[4-(N-alkylamidino)phenyl]homopiperazines as anti-Pneumocystis carinii agents. Bioorg Med Chem Lett 11:2679-81
Mandal, T K; Bostanian, L A (2000) Effect of peptide loading and surfactant concentration on the characteristics of physically crosslinked hydrogel. Pharm Dev Technol 5:555-60
Mandal, T K (2000) Swelling-controlled release system for the vaginal delivery of miconazole. Eur J Pharm Biopharm 50:337-43

Showing the most recent 10 out of 17 publications